Style | Citing Format |
---|---|
MLA | Faraji S, et al.. "Predicting Immunohistochemical Biomarkers of Breast Cancer Using 18F-Fdg Pet/Ct Radiomics: A Multicenter Study." Journal of Medical and Biological Engineering, vol. 44, no. 5, 2024, pp. 749-762. |
APA | Faraji S, Emami F, Vosoughi Z, Hajianfar G, Naseri S, Samimi R, Vosoughi H, Geramifar P, Zaidi H (2024). Predicting Immunohistochemical Biomarkers of Breast Cancer Using 18F-Fdg Pet/Ct Radiomics: A Multicenter Study. Journal of Medical and Biological Engineering, 44(5), 749-762. |
Chicago | Faraji S, Emami F, Vosoughi Z, Hajianfar G, Naseri S, Samimi R, Vosoughi H, Geramifar P, Zaidi H. "Predicting Immunohistochemical Biomarkers of Breast Cancer Using 18F-Fdg Pet/Ct Radiomics: A Multicenter Study." Journal of Medical and Biological Engineering 44, no. 5 (2024): 749-762. |
Harvard | Faraji S et al. (2024) 'Predicting Immunohistochemical Biomarkers of Breast Cancer Using 18F-Fdg Pet/Ct Radiomics: A Multicenter Study', Journal of Medical and Biological Engineering, 44(5), pp. 749-762. |
Vancouver | Faraji S, Emami F, Vosoughi Z, Hajianfar G, Naseri S, Samimi R, et al.. Predicting Immunohistochemical Biomarkers of Breast Cancer Using 18F-Fdg Pet/Ct Radiomics: A Multicenter Study. Journal of Medical and Biological Engineering. 2024;44(5):749-762. |
BibTex | @article{ author = {Faraji S and Emami F and Vosoughi Z and Hajianfar G and Naseri S and Samimi R and Vosoughi H and Geramifar P and Zaidi H}, title = {Predicting Immunohistochemical Biomarkers of Breast Cancer Using 18F-Fdg Pet/Ct Radiomics: A Multicenter Study}, journal = {Journal of Medical and Biological Engineering}, volume = {44}, number = {5}, pages = {749-762}, year = {2024} } |
RIS | TY - JOUR AU - Faraji S AU - Emami F AU - Vosoughi Z AU - Hajianfar G AU - Naseri S AU - Samimi R AU - Vosoughi H AU - Geramifar P AU - Zaidi H TI - Predicting Immunohistochemical Biomarkers of Breast Cancer Using 18F-Fdg Pet/Ct Radiomics: A Multicenter Study JO - Journal of Medical and Biological Engineering VL - 44 IS - 5 SP - 749 EP - 762 PY - 2024 ER - |